Patients who are filing Ozempic vision loss lawsuits against Novo Nordisk had developed nonarteritic anterior ischemic optic neuropathy (NAION) while using Ozempic. These cases are product liability failure to warn lawsuits filed against the responsible drug company, Novo Nordisk, because the Ozempic drug label does not warn about NAION as a possible eye side effect that can cause blindness.
Here are some of the allegations made in recently filed Ozempic vision loss lawsuits:
- Despite available information, the drug company Novo Nordisk failed to warn patients about the risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) when using Ozempic.
- Novo Nordisk knew or should have known that there was reasonable evidence of a causal association between the use of Ozempic and NAION based on preclinical trials, premarket clinical trials, post-market surveillance, and adverse event reports about NAION being associated with Ozempic or other semaglutide drugs, such as Wegovy and Rybelsus.
- A patient who suffered blindness due to NAION would not have used Ozempic — whether for type 2 diabetes treatment or as a weight-loss medication — if they had been provided a warning by Novo Nordisk about the risk of developing NAION when using Ozempic.
We have been investigating Ozempic vision loss lawsuits for almost a year now, starting soon after we published this article, “Wegovy, Rybelsus, and Ozempic Eye Side Effects: Semaglutide Linked to NAION“, on our Drug Injury Watch website back in early July 2024.
As indicated above, patients who have been diagnosed with semaglutide-related NAION and experienced blindness or vision loss may be entitled to legal compensation by filing a drug injury lawsuit against Novo Nordisk, the pharmaceutical company responsible for Ozempic, Wegovy, and Rybelsus.
Let us know if we can assist you or someone you know with an Ozempic vision loss lawsuit involving NAION. Call (910) 256-2971 to speak directly to attorney Tom Lamb about a possible Ozempic drug injury lawsuit.
[View article at original source]Ozempic / Rybelsus / Wegovy
Free Case Evaluation
Strictly Confidential, No Obligation